- Mofolo screened 1,266 women from April to September 2026, up from 431 a year earlier.
- The figures cover two pilot sites and count screenings only.
- Vaccination, screening and access to treatment each have a separate 2030 target.
Inside this story 2 perspectives
At Mofolo Community Health Centre in Gauteng, 1,266 women were screened for cervical cancer between April and September this year. In the same six months last year, the figure was 431. At Ceza Hospital in KwaZulu-Natal, screenings rose from 869 to 1,086. The Department of Health released the figures on 17 November, World Cervical Cancer Elimination Day.
Both facilities are testing ways to connect screening with treatment. For a woman who has taken time away from her job or arranged for someone to collect a child, completing the test is one achievement. Getting an understandable result and a firm next appointment, if she needs one, is another. Counting the first is much easier than tracing the second.
What the pilot figures tell us
The increases show that these two sites screened more women than they did over the comparable period. They do not tell us how many women had an abnormal result, how many received treatment, or how quickly they received it. The department's figures also cannot establish which part of the pilot caused the increase. They are an early signal from two facilities in different provinces, with different starting numbers.
South Africa is expanding access to tests for the DNA of the human papillomavirus, or HPV. Persistent infection with certain types can cause changes in cervical cells that may progress to cancer. A positive HPV screen on its own is not a cancer diagnosis. Explaining that distinction, what further assessment involves and how someone will receive her results is part of delivering the test.
Three targets, three groups of people
The international strategy sets separate goals for 2030. Countries aim to vaccinate 90% of girls against HPV by age 15, screen 70% of women with a high-performance test by age 35 and again by 45, and provide appropriate treatment to 90% of women identified with cervical disease. These percentages describe population goals. An individual's screening schedule can differ, including for women living with HIV.
In South Africa's February and March school campaign, 428,395 girls in Grades 5 to 7 received the vaccine. The department reported 90.6% coverage for that campaign. Girls outside its reach matter to the national goal too. The department says it is planning how to extend services to girls who are out of school.
The natural follow-up to the two clinics' screening totals is a question that can travel well beyond South Africa. Among the women whose results called for more care, how many completed the next step? The answer would help a clinic decide whether its next investment belongs in testing capacity, a reliable way to return results, or the treatment appointment at the far end of a referral.



